In animal studies, all tested ADs have shown teratogenicity or embryotoxicity.' 56 Two studies of nurses occupationally exposed to ADs showed relative risks (RRs) for miscarriages of 2 30 (95% confidence interval (95% CI) 1 204-39) and 1 70 (95% CI 10-2-8) respectively.78 No safety measures was taken during drug preparation in these study groups. Two other studies have shown increased risks for congenital malformations among health personnel handling ADs; a Finnish study found an odds ratio (OR) of 4-7 (p = 0-02) for malformations in the offspring of nurses handling ADs,9 and a Canadian study found eight malformations compared to 4 05 expected (p = 0 05) in offspring of nurses and doctors who had administered ADs early in pregnancy.'" No information on safety measures was given in these studies. There were no clusters of specific malformations.
on reproduction. As the study is as yet the only negative one in a well protected setting, it should be followed up by other studies of well protected health personnel handling ADs. The findings concerning the leukaemia risk, although based on small numbers, encourage larger studies.
Antineoplastic drugs (ADs) constitute a heterogenous group of chemicals that share the ability to inhibit tumour cell growth while exerting tolerable toxicity on normal body cells. They have been used in the treatment of malignant diseases for more than 40 years, and the number of cancers eligible for medical treatment has been steadily expanding.
During the past decade conclusive evidence has accumulated that treatment of malignant as well as non-malignant diseases with alkylating ADs carries a substantial risk of second malignancies, most notably acute non-lymphocytic leukaemia.1 Bladder cancer caused by the alkylating agent cyclophosphamide was first shown among patients treated with immunosuppressive drugs for non-malignant diseases. 24 In animal studies, all tested ADs have shown teratogenicity or embryotoxicity.' 56 Two studies of nurses occupationally exposed to ADs showed relative risks (RRs) for miscarriages of 2 30 (95% confidence interval (95% CI) 1 204-39) and 1 70 (95% CI 10-2-8) respectively.78 No safety measures was taken during drug preparation in these study groups. Two other studies have shown increased risks for congenital malformations among health personnel handling ADs; a Finnish study found an odds ratio (OR) of 4-7 (p = 0-02) for malformations in the offspring of nurses handling ADs,9 and a Canadian study found eight malformations compared to 4 05 expected (p = 0 05) in offspring of nurses and doctors who had administered ADs early in pregnancy.'" No information on safety measures was given in these studies. There were no clusters of specific malformations.
We have carried out a study of leukaemia and nonHodgkin's lymphoma among physicians who have worked with ADs." The RR for leukaemia was 
Material and methods
The study group included female nurses who potentially had been exposed to ADs through their work in one of the five 'old' oncology departments in Denmark. Four of these have operated throughout the whole period in which nurses have taken part in the preparation or administration of ADs-that is, since the early 1970s. The last one started in 1976. An internal control group of about double the number of potentially exposed nurses was established by identifying nurses employed in the same period in other departments in the same hospitals, assumed to be comparable with the oncology departments with regard to lifting, shiftwork, and general work strain.
All nurses were identified by means of records kept by the administration at the hospitals. The identity was verified in the central population register. Thirty seven persons could not be identified and were excluded from the study. Included in the cohort thereafter were 1282 nurses from oncology departments and 2572 from control departments. The criterion of exposure was preparation or administration of ADs. The head nurses of the oncology departments provided data about preparation and administration of the drugs for individual cohort members. In two of the departments old lists existed of the weekly number and type of treatments given in the departments. Since all day-shift nurses had participated equally in this work the individual exposure could be quantified as number oftreatments prepared, or administered, or both a week. In two other departments, the head nurses (assisted by senior staff members) indicated the exposure semiquantitatively as high, medium, low, and no exposure. In the last (and smallest) of the oncology departments exposure could only be given as yes or no.
For the analyses, the quantitative assessments were aggregated with the semiquantitative by grouping four or more treatments a week as high exposure, two to three treatments a week as medium, one treatment a week as low, and none as no exposure. Observations with yes or no information only were not included in the semiquantitative analyses. Information about safety measures was collected by interview with head nurses and senior staffmembers.
IDENTIFICATION OF OUTCOME
The outcomes of interest (miscarriages, congenital malformations, birth weight, gestational age and prematurity, and cancer) were identified through record linkages by means of the unique 10 digit identification number possessed by all Danes. All children born by the study nurses during 1973-88 were identified in the Danish birth register, which has been computerised since 1973. Multiple births were excluded. Remaining were 286 children born to mothers employed in oncology departments during pregnancy and 770 children born to mothers employed in reference departments during pregnancy (table 1) . With only five stillbirths in the two groups together, this outcome was not analysed.
Data about miscarriages came mainly from the hospital discharge register, which has operated since 1977. Induced abortions were added from the register of induced abortions, and a few miscarriages were added from the register ofcongenital malformations, which has operated since 1983. Eighteen abortions were identified among nurses employed in oncology departments during pregnancy and 65 abortions among nurses employed in control departments during pregnancy in the period 1977-88 (table 1) .
Malformations were identified by linkage with the hospital discharge register, the Danish birth register, and the register of congenital malformations. Sixteen children with malformations were identified among the offspring of nurses employed in oncology departments during pregnancy and 43 among the offspring of nurses employed in control departments during pregnancy in the period 1973-88.
Incident cancers in the group of oncology nurses were identified in the Danish cancer registry until 31 December 1987. The Danish cancer registry has operated since 1943. ORs of miscarriages were computed as the compared groups of miscarriages An exposure may affect the birth weight by shortening the duration of gestation or by decreasing the intrauterine growth rate. In the present material, the mean gestational age for liveborn children of mothers in the exposed group was 39-64 weeks compared with 39-69 weeks in the control group. Thus the duration of gestation was practically identical between the groups.
To adjust for possible confounding, the growth rate was analysed in a multiple linear regression model that, as well as the exposure, included the available data on known risk factors-namely, gestational age, pregnancy order, and the sex of the child. These three factors showed the expected associations. Handling ADs during pregnancy was associated with a 56 g lowering of the birth weight, but the association was not significant at the 5% level (table 5) .
In an alternative analysis of birth weight, low birth weight was defined as 2500 g or less and normal birth weight as more than 2500 g. The OR for low birth weight according to this definition among those exposed to ADs was 1-06 (95% CI 0 42-2 67) ( (14) was close to the expected corresponding to an RR of 1-20 (table 6). The only significantly increased site was lymphatic and haematopoietic tissue where the increased risk was due to two cases of leukaemia, giving an RR for leukaemia of 10-65 (95% CI 1-29-38-5).
One of the patients with leukaemia had prepared five treatments of ADs a week during the period 1974-7. In 1977 she developed Hodgkin's disease (stage 2b) and had radiation therapy exclusively. A few months later she developed acute myeloblastic leukaemia. The other case of leukaemia (chronic myeloid) was diagnosed in 1987 in a nurse who had prepared five treatments a week for four months in 1982.
Discussion
The overall risk estimates were not increased for miscarriages, malformations, low birth weight, or preterm birth among the offspring ofnurses handling ADs during pregnancy. The sex ratio was normal. The RR for leukaemia was significantly increased, but this was based on only two cases, one of acute myeloblastic and one of chronic myeloid leukaemia. No information was available about possible confounding factors such as tobacco smoking and alcohol consumption for adverse reproductive outcome. Instead of collecting this information, we chose to identify a control group as similar to the study group as possible except for the exposure to ADs. One advantage of this method is that it is likely to avoid confounding, not only from known risk factors but also from any unknown risk factors. The control group of nurses employed in the same hospitals is identical to the study group with regard to social group and employment, and is probably comparable for work load and smoking and drinking habits. The 1980 should not lead to the conclusion that no increased risks existed in the unprotected setting before 1980. The overall risk estimates for miscarriages and malformations, which are then mainly estimating the risk in the well protected setting after 1980, had acceptable precision, and some confidence in the lack of excess risks for adverse reproductive outcome in this period can also be gained from the consistency between the findings for all outcomes, and from the lack of dose-response relations.
Two studies have found increased risks for miscarriages among nurses handling ADs. A French The precision of the risk estimate for leukaemia was low, although formally the risk was significantly increased. The two leukaemia cases both have some special traits, but when we compute the expected number of cases in the study group, this figure also includes the special cases such as secondary leukaemia after treatment. Finally, it should be taken into consideration that an increased RR for leukaemia was indicated, although also based on small numbers, in our study of physicians handling ADs."l Studies of patients treated with ADs have left no doubt that ADs may cause cancer and animal studies have consistently shown an adverse reproductive outcome. The exposure to ADs has been assessed in many studies, and although it has been shown that the exposure of the health personnel is smaller than the doses received by patients treated with ADs,'5 1820 the study of the risk of cancer and adverse reproductive outcome among the health personnel is important for two reasons. Firstly, from the worker's protection point ofview it is important to monitor the possible risk. Secondly, assessment of the effects in humans of low dose exposures to agents known to be genotoxic at high doses is important.
Regarding reproductive outcome the present study gives some confidence that the safety measures implemented in the Danish oncology departments around 1980 can protect health personnel against adverse effects of ADs on reproduction. As the study is as yet the only negative one in a well protected setting, it should be followed up by other studies of well protected health personnel handling ADs. The findings concerning the risk of leukaemia, although based on small numbers, encourage larger studies. 
